Brain

Biomarker Analysis Publication Highlights Key Signals of Disability Worsening Associated With Neuromyelitis Optica Spectrum Disorder (NMOSD) Attacks, Illustrates Efficacy of UPLIZNA® (inebilizumab-cdon)

Retrieved on: 
Thursday, June 1, 2023
Research, Neurology, Genetics, Clinical Trials, Biotechnology, Pharmaceutical, Health, Optical, Science, Other Science, Brainstem, L1, Attack, Glial fibrillary acidic protein, Serum, Disability, Spinal cord, RCP, Heinrich Heine University Düsseldorf, Philip Niarchos, Expanded Disability Status Scale, Prognosis, NMOSD, Brain, Medicine, Biomarker, Department of Neurology, Xuanwu hospital, Disease management, EDSS, Medical school, Journal, Journal of Neurology, Neurosurgery, and Psychiatry, Patient, Risk, Randomized controlled trial, Psychiatry, Optic nerve, Neurosurgery, Disease, Medical imaging

NMOSD is most notably associated with acute attacks, which can cause irreversible damage to the optic nerve, spinal cord, brain and brain stem.

Key Points: 
  • NMOSD is most notably associated with acute attacks, which can cause irreversible damage to the optic nerve, spinal cord, brain and brain stem.
  • Disease management goals are focused on prevention of attacks, as well as understanding and tracking biomarkers that could signal these attacks.
  • The strong link suggests that higher sNfL levels may be associated with more severe attacks and increased risk of residual disability.
  • Compared with placebo, UPLIZNA was shown to hinder biomarker elevation during attacks while reducing biomarker levels over time in the absence of attacks.

Melmark New England Celebrates Twenty-Five Years of Mission First Moments Serving Individuals with Autism, Intellectual and Developmental Disabilities

Retrieved on: 
Thursday, June 1, 2023
ABA, Massachusetts Association for the Blind and Visually Impaired, Berklee College of Music, WCVB, DSP, Citation, Spectrum, Woman, Applied behavior analysis, Multimedia, Disability studies, Axis, Organization, Congress, News presenter, MD, Brain, Intellectual, McLean Hospital, Gerald Loeb Lifetime Achievement Award winners, MAGIC, CARES Act, Commonwealth, Nursing, Management

Leading the evening's ceremonies, nearly 300 guests also enjoyed co-emcees Cindy Fitzgibbon of WCVB StormTeam 5 and Kendra Petrone, MAGIC 106.7's morning co-host.

Key Points: 
  • Leading the evening's ceremonies, nearly 300 guests also enjoyed co-emcees Cindy Fitzgibbon of WCVB StormTeam 5 and Kendra Petrone, MAGIC 106.7's morning co-host.
  • Thomas Crofcheck, Vice President and Chief Financial Officer, shared his thoughts on the state of employee wages.
  • Crofcheck said "Human services organizations rely on direct support professionals who are predominantly women, people of color, and immigrants.
  • Despite the fact that some public funding agencies do not support annual DSP wage increases, Rita did it anyway.

Infrared Imaging Market Zooms Towards Billion-Dollar Valuation: Estimated to Reach USD 12.17 Billion by 2030: Verified Market Research®

Retrieved on: 
Thursday, June 1, 2023
Infrared, Surgeon, IR, Depression, Prevalence, Schizophrenia, Perfusion, Cancer, Brain, USD, Mr. Meecher, the Uncool Teacher, Patient, Aerospace, Growth, Health, Cooling, Alzheimer's disease, Safety, Breast cancer, Medical imaging, Automotive industry, Wavelength

JERSEY CITY, N.J., June 1, 2023 /PRNewswire/ -- The Global Infrared Imaging Market is projected to grow at a CAGR of 7.70% from 2023 to 2030, according to a new report published by Verified Market Research®. The report reveals that the market was valued at USD 6.24 Billion in 2021 and is expected to reach USD 12.17 Billion by the end of the forecast period.

Key Points: 
  • The report provides an in-depth analysis of the global Infrared Imaging Market, including its growth prospects, market trends, and market challenges.
  • The report reveals that the market was valued at USD 6.24 Billion in 2021 and is expected to reach USD 12.17 Billion by the end of the forecast period.
  • Infrared imaging, a non-invasive technique utilizing infrared radiation for disease detection, is revolutionizing the healthcare industry.
  • Additionally, near infrared imaging market exhibits great potential in identifying coronary artery blockages, further expanding its applications in cardiovascular health.

Infrared Imaging Market Zooms Towards Billion-Dollar Valuation: Estimated to Reach USD 12.17 Billion by 2030: Verified Market Research®

Retrieved on: 
Thursday, June 1, 2023
Infrared, Surgeon, IR, Depression, Prevalence, Schizophrenia, Perfusion, Cancer, Brain, USD, Mr. Meecher, the Uncool Teacher, Patient, Aerospace, Growth, Health, Cooling, Alzheimer's disease, Safety, Breast cancer, Medical imaging, Automotive industry, Wavelength

JERSEY CITY, N.J., June 1, 2023 /PRNewswire/ -- The Global Infrared Imaging Market is projected to grow at a CAGR of 7.70% from 2023 to 2030, according to a new report published by Verified Market Research®. The report reveals that the market was valued at USD 6.24 Billion in 2021 and is expected to reach USD 12.17 Billion by the end of the forecast period.

Key Points: 
  • The report provides an in-depth analysis of the global Infrared Imaging Market, including its growth prospects, market trends, and market challenges.
  • The report reveals that the market was valued at USD 6.24 Billion in 2021 and is expected to reach USD 12.17 Billion by the end of the forecast period.
  • Infrared imaging, a non-invasive technique utilizing infrared radiation for disease detection, is revolutionizing the healthcare industry.
  • Additionally, near infrared imaging market exhibits great potential in identifying coronary artery blockages, further expanding its applications in cardiovascular health.

MedStar Health Teams up with Local Sports Figures to Teach CPR and AED with Video Campaign Launched for CPR & AED Awareness Week

Retrieved on: 
Thursday, June 1, 2023
Survivor, Heart, CSCS, Critical care, AED (non-profit), Cardiac arrest, Nerve, Life, Georgetown, Public, Oxygen, Survival, Season, NHL, Woman, Rehabilitation, Brain, Multimedia, MedSTAR, Athletic, Washington Wizards, MedStar Health, Massage, Association football, Athlete, Wizard, Capital, AED, Buffalo Bills, Physician, Nursing care plan, ATC, CPR, DPT, Female, Nursing, Mobile phone, Washington Mystics, MD, Washington Capitals

COLUMBIA, Md., June 1, 2023 /PRNewswire/ -- Emergency and critical care physicians from MedStar Health have teamed up with former and current players and staff from local sports teams to teach CPR and how to use an Automated External Defibrillator (AED) with a video campaign to address disparities in who is most likely to receive life-saving CPR from a bystander.

Key Points: 
  • We know that bystander CPR saves lives, and we hope these videos will connect with people and help them overcome any fears or hesitations."
  • Teams participating in the three-minute videos include the Washington Wizards, Washington Capitals, Washington Mystics, and Georgetown Women's Soccer.
  • Recent changes to the way CPR can be administered should also make the public feel more comfortable performing CPR, according to MedStar Health physicians.
  • MedStar Health social media channels are running the videos that will also be shared by the teams.

TRAZER INC. INTRODUCES TRAZER® XP

Retrieved on: 
Thursday, June 1, 2023
Neuromechanics, Acceleration, University of Alabama, University, Siderian, CATS, Kinematics, Elite Performance, XP, Rehabilitation, Brain, Multimedia, Falls, Associate, Movement, Dead Man Walking, Risk, AD, Sports medicine, Online shopping, Balance

CLEVELAND, June 1, 2023 /PRNewswire/ -- TRAZER INC., a leader in movement technology, is pleased to announce the release of TRAZER XP. TRAZER is a multi-patented technology designed for rehabilitation, athletic training, and enhancing human performance. The TRAZER system is unique in its ability to strengthen the connection between the brain + body™ regardless of age or level of physical capability. With applications across healthcare, senior care, rehabilitation, sports medicine, and sports performance, TRAZER empowers professionals with actionable data.

Key Points: 
  • CLEVELAND, June 1, 2023 /PRNewswire/ -- TRAZER INC., a leader in movement technology, is pleased to announce the release of TRAZER XP.
  • The TRAZER system is unique in its ability to strengthen the connection between the brain + body™ regardless of age or level of physical capability.
  • With applications across healthcare, senior care, rehabilitation, sports medicine, and sports performance, TRAZER empowers professionals with actionable data.
  • TRAZER XP strengthens the connection between the brain + body™ regardless of age or level of physical capability.

EPOS Launches New IMPACT 1000 Bluetooth Headset Series

Retrieved on: 
Thursday, June 1, 2023
Microsoft Teams, OpenOffice, ANC, Communication, Speech, Red Dot, Philadelphia Daily News Open, Microsoft, Brain, Element, Movement, Science, IMPACT, Machine learning, Environment, EPOS, Mobile phone, Cassette tape, Telescopic sight

COPENHAGEN, Denmark, June 1, 2023 /PRNewswire/ -- EPOS, the global audio brand, today announces that the IMPACT 1000, an on-ear, future-proof Bluetooth® headset, is available for purchase. Designed for professionals who value clear communication, the IMPACT 1000 ensures all meeting participants can stay focused - even in noisy environments.

Key Points: 
  • COPENHAGEN, Denmark, June 1, 2023 /PRNewswire/ -- EPOS, the global audio brand, today announces that the IMPACT 1000, an on-ear, future-proof Bluetooth® headset, is available for purchase.
  • Designed for professionals who value clear communication, the IMPACT 1000 ensures all meeting participants can stay focused - even in noisy environments.
  • Leveraging insights such as these, EPOS develops machine learning technologies such as those in the IMPACT 1000 to help end-users' brains better process and understand audio stimuli.
  • IMPACT 1000 features EPOS BrainAdapt™ technology to reduce brain fatigue with hybrid adaptive Active Noise Cancellation (ANC) and industry-leading voice pickup powered by EPOS AI™.

BIORCHESTRA Invited to Present Update on Central Nervous System Lead Program (BMD-001) and IV-Formulated siRNA Data at BIO2023 International Conference

Retrieved on: 
Thursday, June 1, 2023
Rapunzel's Tangled Adventure (season 2), Drug discovery, Pathology, ALS, RNA, DSM-IV codes, CNS, Central nervous system, Small RNA, Central nervous system disease, Amyloid, Parkinson's disease, Myenteric plexus, ASO, RNA interference, NHP, FDA, IND, Alzheimer's disease, Disease, Vaccine, Medical imaging, Pharmaceutical industry, Nanomedicine, Brain

ET, Room 104A

Key Points: 
  • ET, Room 104A
    Drug delivery platform expanded to previously inaccessible neurological diseases, including brain cancers
    CAMBRIDGE, Mass.
  • The conference, the largest in the industry, is scheduled for June 5 - 8, 2023, in Boston.
  • Ahead of engagements with the FDA regarding an Investigational New Drug (IND) pathway, the company expects to complete IND enabling work in 2024.
  • Today's results further strengthen BMD-001 within our neurodegenerative diseases franchise targeting Alzheimer's disease, Amyotrophic Lateral Sclerosis, and Parkinson's disease."

CAMH study confirms ongoing brain inflammation associated with long COVID

Retrieved on: 
Thursday, June 1, 2023
Inflammation, Depression, Anxiety, CAMH, COVID-19, Hope, PET, Brain, Research, COVID, Amnesia, Parkinson's disease, Patient, TSPO, Psychiatry, Motivation, JAMA Psychiatry, Encephalitis, Memory, Fatigue, Pharmaceutical industry, Medical imaging, Medical device

TORONTO, June 1, 2023 /CNW/ - A new CAMH study published in the journal JAMA Psychiatry found elevated levels of inflammation in the brain of patients who report persistent symptoms of long COVID.

Key Points: 
  • TORONTO, June 1, 2023 /CNW/ - A new CAMH study published in the journal JAMA Psychiatry found elevated levels of inflammation in the brain of patients who report persistent symptoms of long COVID.
  • "We already knew that there is brain inflammation in people who died in the midst of a severe, active COVID-19 infection.
  • "Inflammation in the brain was suspected of being the critical step in causing neurological and psychiatric symptoms of long COVID so confirming this is vital to develop treatments for people experiencing symptoms."
  • Most participants also experienced a variety of other lingering symptoms associated with long COVID, including extreme fatigue and problems with concentration and memory often referred to as 'brain fog'.

Cytomegalovirus lies dormant in most US adults and is the leading infectious cause of birth defects, but few have heard of it

Retrieved on: 
Thursday, June 1, 2023
Infection, Medicine, Learning, Pregnancy, Food, Legislation, Awareness, Cytomegalovirus, HIV, Hearing loss, Education, Urine, Rubella, Fetus, Toxoplasmosis, Parent, Prenatal care, Native, Fever, Clinical trial, Birth defect, Meal, Chickenpox, Brain, Research, Risk, Cerebral palsy, Down syndrome, Incidence, Groundnut rosette virus, Food and Drug Administration, Hospital, Population, Child, CMV, Immune system, Stillbirth, Glycine mollis, Diagnosis, Infant, Birth, Outline of counseling, Fluid mechanics, Death, Virus, Family, Valaciclovir, Syphilis, Saliva, Fatigue, Disease, Vaccine, Birth control, Dietary supplement, Pharmaceutical industry

CMV belongs to the same virus family as cold sores and chickenpox and, like those viruses, lives in the body for life.

Key Points: 
  • CMV belongs to the same virus family as cold sores and chickenpox and, like those viruses, lives in the body for life.
  • Most children and adults experience very mild or even no symptoms with their initial infection.
  • Congenital CMV, or cCMV, is the most common infection before birth and the leading infectious cause of birth defects.
  • Black and Native American infants also have a higher risk of death from cCMV compared to white infants.

Looking for CMV during pregnancy

    • If CMV can infect a fetus and cause birth defects, then why aren’t pregnant people tested and treated for this virus too?
    • Prenatal CMV screening is not standard of care due to several limitations of the current testing approach.
    • Biweekly antibodies against CMV seem to reduce fetal transmission when given around conception or during the first trimester, but CMV is rarely diagnosed that early in pregnancy.
    • In general, valacyclovir does not work as well as other CMV drugs that people cannot take during pregnancy.

Screening newborns for CMV

    • An accurate CMV test for newborns is available, and many studies support the benefit of early CMV diagnosis.
    • While some birth centers provide early CMV testing, most U.S. states do not mandate newborn CMV screening.
    • In February 2022, Minnesota became the first – and remains the only – state to require CMV screening of all newborns, although Massachusetts and Indiana have pending universal screening bills.
    • Most newborns with cCMV appear physically normal at birth and develop normally over their lifetime, leading some to question the benefits of CMV screening for those children.

Spreading CMV awareness, not infection

    • Most people have not heard of CMV or are unwaware of what they can do to reduce their chances of getting CMV during pregnancy.
    • Many adults are repeatedly exposed to one of the major risk factors for CMV infection: a young child who regularly attends large-group child care.
    • Children can appear quite healthy but carry CMV in their saliva and urine for weeks or even months after infection.